Ostrum Asset Management Jazz Pharmaceuticals PLC Transaction History

Ostrum Asset Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$115.19 - $132.77 $490,248 - $565,069	4,256 Added 22.6%	23,085 $2.78 Billion
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $357,062 - $425,000	-3,125 Reduced 14.23%	18,829 $2.32 Billion
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $292,678 - $348,598	2,399 Added 12.27%	21,954 $2.84 Billion
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $2,082 - $2,501	17 Added 0.09%	19,555 $2.42 Billion
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $2.62 Million - $3.14 Million	19,538 New	19,538 $2.86 Billion

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

Stay updated on Ostrum Asset Management with notifications on news.